C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/16/2004	CA2524229A1 Canine ghrh gene, polypeptides and methods of use
12/16/2004	CA2523879A1 A coumermycin/novobiocin-regulated gene expression system
12/16/2004	CA2518627A1 Method of screening antiobesity agents and animal model of obesity
12/15/2004	EP1486571A1 Method for the recombinant production of polypeptides
12/15/2004	EP1486570A1 Method for producing L-amino acid
12/15/2004	EP1486567A1 Improved adeno-associated virus (AAV) vector for gene therapy
12/15/2004	EP1486566A1 Proteins capable of binding to female sex hormones and process for producing the same
12/15/2004	EP1486565A1 Combination PDGF, KGF, IGF, and IGFBP for wound healing
12/15/2004	EP1486564A1 SiRNA with increased stability in serum
12/15/2004	EP1486563A1 Embryonically modified animal and method of constructing the same
12/15/2004	EP1486560A2 Specific antibodies and antibody fragments for TGFBETA1
12/15/2004	EP1486511A1 Refolding of polypeptides
12/15/2004	EP1486510A1 Transporter gene OATP- C
12/15/2004	EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition
12/15/2004	EP1486505A1 Angiotensin derivatives
12/15/2004	EP1485719A2 Peptide epitopes common to antigens of the same multigene family
12/15/2004	EP1485709A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
12/15/2004	EP1485506A2 Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes
12/15/2004	EP1485505A1 Melting temperature dependent dna amplification
12/15/2004	EP1485504A2 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits
12/15/2004	EP1485503A2 Improved nucleic acid amplification
12/15/2004	EP1485502A2 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof
12/15/2004	EP1485499A1 Novel primers for screening schizophrenia and a method thereof
12/15/2004	EP1485498A2 Synthesis of synthons for the manufacture of bioactive compounds
12/15/2004	EP1485497A2 Ricin vaccine and methods of making and using thereof
12/15/2004	EP1485496A2 Deracemisation of amines
12/15/2004	EP1485493A1 Novel method for the production of hybrid maize seeds
12/15/2004	EP1485492A2 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants
12/15/2004	EP1485491A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
12/15/2004	EP1485490A2 Yield-related polynucleotides and polypeptides in plants
12/15/2004	EP1485489A2 Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof
12/15/2004	EP1485488A2 Recombinant negative strand virus rna expression systems and vaccines
12/15/2004	EP1485487A2 Cartilage regeneration using chondrocyte and tgf-beta
12/15/2004	EP1485486A2 Optimizing glycan processing in plants
12/15/2004	EP1485485A1 Transdifferentiation of cells and tissues
12/15/2004	EP1485484A2 Antigen fragments for the diagnosis of toxoplasma gondii
12/15/2004	EP1485483A1 Proteolysis resistant active vegf
12/15/2004	EP1485482A1 Inhibition of the beta3 subunit of l-type ca 2+ channels
12/15/2004	EP1485481A2 Fluorescent protein from aequorea coerulescens and uses thereof
12/15/2004	EP1485480A2 Cd40 splice variants, method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof
12/15/2004	EP1485479A2 Stem cell culture
12/15/2004	EP1485478A1 Method of repressing flowering in a plant
12/15/2004	EP1485477A2 Novel type-1 cytokine receptor glm-r
12/15/2004	EP1485476A2 Dimeric tf antagonist
12/15/2004	EP1485475A1 Hybrid and single chain meganucleases and use thereof
12/15/2004	EP1485471A1 Alcohol dehydrogenases with high solvent and temperature stability
12/15/2004	EP1485470A2 Use of xylene monooxygenase for the oxidation of substituted monocyclic aromatic compounds
12/15/2004	EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
12/15/2004	EP1485467A2 Recombinant expression vectors for functional na sb v /sb 1.9 sodium channels
12/15/2004	EP1485462A2 Secondary metabolite congener distribution modulation
12/15/2004	EP1485415A2 Neoplasm specific antibodies and uses thereof
12/15/2004	EP1485412A1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy
12/15/2004	EP1485410A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
12/15/2004	EP1485407A1 A mutated immunoglobulin-binding protein
12/15/2004	EP1485406A2 Highly homogeneous molecular markers for electrophoresis
12/15/2004	EP1485405A2 Melanin-concentrating hormone analogs
12/15/2004	EP1485402A2 Selective extraction of dna from groups of cells
12/15/2004	EP1485401A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(-2-methoxyl)ethyl modifications
12/15/2004	EP1485400A2 Human rnase iii and compositions and uses thereof
12/15/2004	EP1485398A2 Methods of screening for compounds that modulate hormone receptor activity
12/15/2004	EP1485397A2 Trans-splicing mediated imaging of gene expression
12/15/2004	EP1485346A1 Novel positively charged lipids and liposomes comprising the positively charged lipids
12/15/2004	EP1485130A2 Reagents and treatment methods for autoimmune diseases
12/15/2004	EP1485129A2 Nanostructures containing pilin protein
12/15/2004	EP1485128A2 Nanostructures containing antibody assembly units
12/15/2004	EP1485126A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
12/15/2004	EP1485124A2 Method of inducing an enhanced immune response against hiv
12/15/2004	EP1485123A2 Method of inducing an enhanced immune response against hiv
12/15/2004	EP1485121A2 Activated protein c formulations
12/15/2004	EP1485109A1 Vascular therapeutics
12/15/2004	EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
12/15/2004	EP1485075A2 Mhc-peptide complex binding ligands
12/15/2004	EP1485056A2 Methods of using fet labeled oligonucleotides that include a'5' exonuclease resistant quencher domain and compositions for practicing the same
12/15/2004	EP1484959A2 Nucleic acid constructs and methods for producing altered seed oil compositions
12/15/2004	EP1461425A4 Novel human hydroxylases and polynucleotides encoding the same
12/15/2004	EP1444363A4 Transfection kinetics and structural promoters
12/15/2004	EP1425065A4 Electrical field stimulation of eukaryotic cells
12/15/2004	EP1421176A4 Nucleic acids and encoded polypeptides associated with bipolar disorder
12/15/2004	EP1404845B1 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
12/15/2004	EP1383903A4 Methods for the production of products in host cells
12/15/2004	EP1328880A4 Interactive correlation of compound information and genomic information
12/15/2004	EP1307562B1 Nucleotide sequences which code for the lysr3 gene
12/15/2004	EP1263779B1 Self antigen vaccines for treating b cell lymphomas and other cancers
12/15/2004	EP1227715A4 Methods for stabilizing and controlling apomixis
12/15/2004	EP1212358B1 Synthetic papillomavirus genes optimized for expression in human cells
12/15/2004	EP1159283A4 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease
12/15/2004	EP1121599B1 Detection and quantification of vancomycin in biological fluids
12/15/2004	EP1121448B1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II
12/15/2004	EP1112379A4 NOVEL AMPLICON IN THE 20q13 REGION OF HUMAN CHROMOSOME 20 AND USES THEREOF
12/15/2004	EP1109931A4 METHOD FOR STUDYING PROTEIN INTERACTIONS $i(IN VIVO)
12/15/2004	EP1073461B1 Viral chimeras comprised of caev and hiv-1 genetic elements
12/15/2004	EP1068309B1 Enterotoxin-deficient bacillus
12/15/2004	EP1025211B1 Hyaluronan synthase gene and uses thereof
12/15/2004	EP1017832B1 Microspore-specific promoter and method for obtaining hybrid plants
12/15/2004	EP1017796A4 Tm4 conditional shuttle phasmids and uses thereof
12/15/2004	EP0988391B1 Recombinant adenoviral vectors comprising a splicing sequence
12/15/2004	EP0977866B1 Fatty acid modifying enzymes from developing seeds of vernonia galamenensis
12/15/2004	EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies
12/15/2004	EP0956304B1 Dendritic cell-specific antibodies
12/15/2004	EP0950112A4 Photolabile polymer array synthesis methods

1 ... 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 ... 4023